Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Speciality Medicines Ltd (NSE: SPML), ISIN INE0R0M01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SPML last traded at ₹147.50 (-4.84%), with a 52-week range of ₹121.10 to ₹381.20 (as of 23 Sep 2026).
Shareholding as of Mar 2026: promoters 43.43%, FIIs 0.24%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 74/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.